2010
DOI: 10.1111/j.2042-3306.2010.00165.x
|View full text |Cite
|
Sign up to set email alerts
|

Comparative study between atropine and hyoscine-N-butylbromide for reversal of detomidine induced bradycardia in horses

Abstract: Hyoscine may represent an alternative to atropine for treating bradycardia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
16
2
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(20 citation statements)
references
References 30 publications
1
16
2
1
Order By: Relevance
“…While atropine has a narrow therapeutic window and readily crosses the blood‐brain barrier, the quaternary ammonium structure of NBB results in poor penetration into the central nervous system, therefore it has not been associated with neurologic side effects. NBB has also been shown to produce only minimal and transient (less than 2 hours) changes in the motility pattern of small and large intestines in horses and to result in a less pronounced tachycardia when compared to atropine for the reversal of detomidine‐induced bradycardia in horses . Based on the minimal side effects associated with NBB, we can conclude that it is safer when compared to atropine when anticholinergic therapy is indicated.…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…While atropine has a narrow therapeutic window and readily crosses the blood‐brain barrier, the quaternary ammonium structure of NBB results in poor penetration into the central nervous system, therefore it has not been associated with neurologic side effects. NBB has also been shown to produce only minimal and transient (less than 2 hours) changes in the motility pattern of small and large intestines in horses and to result in a less pronounced tachycardia when compared to atropine for the reversal of detomidine‐induced bradycardia in horses . Based on the minimal side effects associated with NBB, we can conclude that it is safer when compared to atropine when anticholinergic therapy is indicated.…”
Section: Discussionmentioning
confidence: 93%
“…NBB has also been shown to produce only minimal and transient (less than 2 hours) changes in the motility pattern of small and large intestines in horses 19,20 and to result in a less pronounced tachycardia when compared to atropine for the reversal of detomidine-induced bradycardia in horses. 21 Based on the minimal side effects associated with NBB, we can conclude that it is safer when compared to atropine when anticholinergic therapy is indicated.…”
Section: Discussionmentioning
confidence: 93%
“…Administration of atropine to horses to reverse bradycardia induced by an IV bolus of detomidine caused severe hypertension and tachycardia. 22 However, administration of anticholinergics concurrently during a CRI of xylazine in horses anesthetized with halothane resulted in reversal of bradycardia and improved cardiac output without an excessive increase in MAP or HR. 23,24 In the present study, dexmedetomidine had substantial vasopressor activity that was not associated with significant decreases in global perfusion variables when its negative chronotropic effects were antagonized by atropine administration.…”
Section: Discussionmentioning
confidence: 98%
“…In the literature, hyoscine n-buytlbromide has previously shown a strong analgesic and spasmolytic actions (Murray 2004) and, due to its anti-cholinergic action, administration of this drug has been described to induce a transient tachycardia after administration, which may have altered our findings. The effect of this tachycardia would most likely be countered by the concurrent administration of detomidine chlorhydrate, which would cause a reduction in heart rate to the original baseline value (Pimenta et al 2011). It was not possible from available information to relate the timing of HR decrease to resolution of colic or to administration of drugs, because this was a retrospective study and all such data was not readily available.…”
Section: Pain Evaluationmentioning
confidence: 99%